title: Combination of nonmyeloablative stem cell transplantation and Imatinib in accelerated phase CML.
authors.affiliation: Department of Medicine, Division of Hematology, University of Liège, Belgium.
authors.forename: Frédéric
authors.initials: F
authors.lastname: Baron
authors.forename: Pascale
authors.initials: P
authors.lastname: Frère
authors.forename: Christian
authors.initials: C
authors.lastname: Herens
authors.forename: Georges
authors.initials: G
authors.lastname: Fillet
authors.forename: Yves
authors.initials: Y
authors.lastname: Beguin
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001549:Benzamides; D003131:Combined Modality Therapy; D020732:Cytogenetic Analysis; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*; D012074:Remission Induction / Q000379:methods; D033581:Stem Cell Transplantation / Q000379:methods*; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D014916:Whole-Body Irradiation
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D014740:Vidarabine; C024352:fludarabine